- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01209923
Validation of the Stayhealthy BC1 Body Comp Analyzer
December 14, 2021 updated by: Todd Schroeder, University of Southern California
Validation of the BC1 Bioelectrical Impedance Body Comp Analyzer
The purpose of this study was to validate the Stayhealthy BC1 bioelectrical impedance analyzer to assess percent body fat in children and adults.
The BC1 was compared to dual-energy x-ray absorptiometry assessment of body fat for adults and to hydrostatic weighing assessment of body fat for children.
We hypothesized that the BC1 would provide similar measures of body fat between devices with acceptable limits of agreement.
Study Overview
Detailed Description
The BC1 body composition analyzer is manufactured by Stayhealthy.
It is a handheld, noninvasive bioelectrical impedance device.
When held, the BC1 sends an electrical impulse through the body to determine body fat, muscle mass, and body hydration.
Bio-impedance devices measure the change in electrical resistance in body tissues by using a detectable electrical signal that passes through the body.
The method is based on the principle that lean body mass contains virtually all the water and conducting electrolytes in the body and provides a good electrical pathway.
In contrast, fat or fat-containing tissues produce a poor electrical pathway.
By inducing a low-energy, high -frequency signal, a measurement of the baseline resistance to flow of electrical current can be assessed.
The resistance measurement relates directly to the volume of the conductor.
Through repeated measurements and identifying other parameters (i.e.
gender, weight, age and height) proprietary equations were developed that determine total body water, fat free body mass, and total body fat.
Study Type
Interventional
Enrollment (Actual)
362
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90033
- USC Clinical Exercise Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 80 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- boys and girls 10-17 yrs and men and women 18-80 yrs
Exclusion Criteria:
- acute illness
- pregnancy
- pacemaker or defibrillator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Body composition testing
Body composition tested using bioelectrical impedance (BC1) and the DEXA or hydrostatic weighing methods.
|
Body composition measures taken twice at the same visit for BIA, DEXA, and hydrostatic weighing.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent Body Fat
Time Frame: 2 measures were assessed during a single visit
|
Percent body was compared between devices
|
2 measures were assessed during a single visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Edward T Schroeder, PhD, University of Southern California
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2007
Primary Completion (Actual)
August 1, 2009
Study Completion (Actual)
August 1, 2009
Study Registration Dates
First Submitted
July 16, 2010
First Submitted That Met QC Criteria
September 24, 2010
First Posted (Estimate)
September 27, 2010
Study Record Updates
Last Update Posted (Actual)
January 13, 2022
Last Update Submitted That Met QC Criteria
December 14, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Stayhealthy 01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Composition
-
Efforia, IncRecruiting
-
Dynamical Business and Science Society - DBSS International...Universidad de Córdoba; CES University; ARTHROS Centro de Fisioterapia y EjercicioRecruiting
-
Nova Southeastern UniversityCompleted
-
Centro Universitario de Ciencias de la Salud, MexicoCompleted
-
University of California, San FranciscoHologic, Inc.Completed
-
University of SurreyUnknownBody Composition
-
Texas Woman's UniversityCompleted
-
Efforia, IncRecruiting
-
Efforia, IncRecruiting
-
Universidad de ZaragozaCompleted
Clinical Trials on BC1
-
Peking University First HospitalRecruitingMultiple Myeloma and Malignant Plasma Cell NeoplasmsChina
-
BriaCell Therapeutics CorporationRecruitingBreast Cancer | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the Breast | Tumors, BreastUnited States